{"id":1319,"date":"2024-10-08T14:42:57","date_gmt":"2024-10-08T18:42:57","guid":{"rendered":"https:\/\/cic-mauricie.ca\/etudes-en-cours\/sanofi-act18018\/"},"modified":"2024-10-08T14:42:57","modified_gmt":"2024-10-08T18:42:57","slug":"sanofi-act18018","status":"publish","type":"etudes-en-cours","link":"https:\/\/cic-mauricie.ca\/en\/etudes-en-cours\/sanofi-act18018\/","title":{"rendered":"SANOFI ACT18018"},"content":{"rendered":"\n<p>ACT18018 is a phase II study of the molecule Itepekimab in the management of non-cystic fibrosis bronchiectasis.<\/p>\n\n<p>You may receive different doses of the investigational molecule or a placebo. The treatment is administered by subcutaneous injection. <\/p>\n\n<p>To participate, you must have a received a diagnosis of non-cystic fibrosis bronchiectasis.<\/p>\n\n<p><a href=\"https:\/\/clinicaltrials.gov\/study\/NCT06280391?id=ACT18018&amp;rank=1\" target=\"_blank\" rel=\"noreferrer noopener\">Clic here<\/a> to access the official record from the National Library of Medicine for this study<\/p>\n","protected":false},"featured_media":0,"parent":0,"menu_order":0,"template":"","categories-etudes":[],"class_list":["post-1319","etudes-en-cours","type-etudes-en-cours","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>SANOFI ACT18018 - CIC Mauricie<\/title>\n<meta name=\"description\" content=\"ACT18018 is a phase II study of the molecule Itepekimab in the management of non-cystic fibrosis bronchiectasis. You may receive different doses of the\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cic-mauricie.ca\/en\/etudes-en-cours\/sanofi-act18018\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SANOFI ACT18018 - CIC Mauricie\" \/>\n<meta property=\"og:description\" content=\"ACT18018 is a phase II study of the molecule Itepekimab in the management of non-cystic fibrosis bronchiectasis. You may receive different doses of the\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cic-mauricie.ca\/en\/etudes-en-cours\/sanofi-act18018\/\" \/>\n<meta property=\"og:site_name\" content=\"CIC Mauricie\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cic-mauricie.ca\/wp-content\/uploads\/2023\/11\/bg-02.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1282\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/cic-mauricie.ca\\\/en\\\/etudes-en-cours\\\/sanofi-act18018\\\/\",\"url\":\"https:\\\/\\\/cic-mauricie.ca\\\/en\\\/etudes-en-cours\\\/sanofi-act18018\\\/\",\"name\":\"SANOFI ACT18018 - CIC Mauricie\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/cic-mauricie.ca\\\/#website\"},\"datePublished\":\"2024-10-08T18:42:57+00:00\",\"description\":\"ACT18018 is a phase II study of the molecule Itepekimab in the management of non-cystic fibrosis bronchiectasis. You may receive different doses of the\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/cic-mauricie.ca\\\/en\\\/etudes-en-cours\\\/sanofi-act18018\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/cic-mauricie.ca\\\/en\\\/etudes-en-cours\\\/sanofi-act18018\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/cic-mauricie.ca\\\/en\\\/etudes-en-cours\\\/sanofi-act18018\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/cic-mauricie.ca\\\/en\\\/home\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\u00c9tudes en cours\",\"item\":\"https:\\\/\\\/cic-mauricie.ca\\\/etudes-en-cours\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"SANOFI ACT18018\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/cic-mauricie.ca\\\/#website\",\"url\":\"https:\\\/\\\/cic-mauricie.ca\\\/\",\"name\":\"CIC Mauricie\",\"description\":\"L&#039;excellence en recherche et essais cliniques pharmaceutiques\",\"publisher\":{\"@id\":\"https:\\\/\\\/cic-mauricie.ca\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/cic-mauricie.ca\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/cic-mauricie.ca\\\/#organization\",\"name\":\"CIC Mauricie\",\"url\":\"https:\\\/\\\/cic-mauricie.ca\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/cic-mauricie.ca\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/cic-mauricie.ca\\\/wp-content\\\/uploads\\\/2023\\\/11\\\/logo-cic-mauricie.svg\",\"contentUrl\":\"https:\\\/\\\/cic-mauricie.ca\\\/wp-content\\\/uploads\\\/2023\\\/11\\\/logo-cic-mauricie.svg\",\"width\":426,\"height\":305,\"caption\":\"CIC Mauricie\"},\"image\":{\"@id\":\"https:\\\/\\\/cic-mauricie.ca\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SANOFI ACT18018 - CIC Mauricie","description":"ACT18018 is a phase II study of the molecule Itepekimab in the management of non-cystic fibrosis bronchiectasis. You may receive different doses of the","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cic-mauricie.ca\/en\/etudes-en-cours\/sanofi-act18018\/","og_locale":"en_US","og_type":"article","og_title":"SANOFI ACT18018 - CIC Mauricie","og_description":"ACT18018 is a phase II study of the molecule Itepekimab in the management of non-cystic fibrosis bronchiectasis. You may receive different doses of the","og_url":"https:\/\/cic-mauricie.ca\/en\/etudes-en-cours\/sanofi-act18018\/","og_site_name":"CIC Mauricie","og_image":[{"width":1920,"height":1282,"url":"https:\/\/cic-mauricie.ca\/wp-content\/uploads\/2023\/11\/bg-02.png","type":"image\/png"}],"twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/cic-mauricie.ca\/en\/etudes-en-cours\/sanofi-act18018\/","url":"https:\/\/cic-mauricie.ca\/en\/etudes-en-cours\/sanofi-act18018\/","name":"SANOFI ACT18018 - CIC Mauricie","isPartOf":{"@id":"https:\/\/cic-mauricie.ca\/#website"},"datePublished":"2024-10-08T18:42:57+00:00","description":"ACT18018 is a phase II study of the molecule Itepekimab in the management of non-cystic fibrosis bronchiectasis. You may receive different doses of the","breadcrumb":{"@id":"https:\/\/cic-mauricie.ca\/en\/etudes-en-cours\/sanofi-act18018\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cic-mauricie.ca\/en\/etudes-en-cours\/sanofi-act18018\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/cic-mauricie.ca\/en\/etudes-en-cours\/sanofi-act18018\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/cic-mauricie.ca\/en\/home\/"},{"@type":"ListItem","position":2,"name":"\u00c9tudes en cours","item":"https:\/\/cic-mauricie.ca\/etudes-en-cours\/"},{"@type":"ListItem","position":3,"name":"SANOFI ACT18018"}]},{"@type":"WebSite","@id":"https:\/\/cic-mauricie.ca\/#website","url":"https:\/\/cic-mauricie.ca\/","name":"CIC Mauricie","description":"L&#039;excellence en recherche et essais cliniques pharmaceutiques","publisher":{"@id":"https:\/\/cic-mauricie.ca\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cic-mauricie.ca\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cic-mauricie.ca\/#organization","name":"CIC Mauricie","url":"https:\/\/cic-mauricie.ca\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cic-mauricie.ca\/#\/schema\/logo\/image\/","url":"https:\/\/cic-mauricie.ca\/wp-content\/uploads\/2023\/11\/logo-cic-mauricie.svg","contentUrl":"https:\/\/cic-mauricie.ca\/wp-content\/uploads\/2023\/11\/logo-cic-mauricie.svg","width":426,"height":305,"caption":"CIC Mauricie"},"image":{"@id":"https:\/\/cic-mauricie.ca\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/cic-mauricie.ca\/en\/wp-json\/wp\/v2\/etudes-en-cours\/1319","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cic-mauricie.ca\/en\/wp-json\/wp\/v2\/etudes-en-cours"}],"about":[{"href":"https:\/\/cic-mauricie.ca\/en\/wp-json\/wp\/v2\/types\/etudes-en-cours"}],"wp:attachment":[{"href":"https:\/\/cic-mauricie.ca\/en\/wp-json\/wp\/v2\/media?parent=1319"}],"wp:term":[{"taxonomy":"categories-etudes","embeddable":true,"href":"https:\/\/cic-mauricie.ca\/en\/wp-json\/wp\/v2\/categories-etudes?post=1319"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}